Journal profile · Virology
AIDS Research and Human Retroviruses
ISSN 0889-2229 · eISSN 1931-8405 · Mary Ann Liebert Inc. · UNITED STATES · Monthly · Founded 1987
AIDS Research and Human Retroviruses: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.03; hybrid open access; review 3–6 weeks (community reports); community-reported acceptance: easy; 67 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
AIDS Research and Human Retroviruses is published by Mary Ann Liebert Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are HIV Research and Treatment, HIV/AIDS drug development and treatment and HIV/AIDS Research and Interventions, together about 60.1% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research, focusing on developments in prevention science, novel therapeutics, and immune-restorative approaches. Cutting-edge papers on the latest progress and research advances through clinical trials and examination of targeted antiretroviral agents lead to improvements in translational medicine for optimal treatment outcomes. AIDS Research and Human Retroviruses coverage includes: HIV cure research HIV prevention science - Vaccine research - Systemic and Topical PreP Molecular and cell biology of HIV and SIV Developments in HIV pathogenesis and comorbidities Molecular biology, immunology, and epidemiology of HTLV Pharmacology of HIV therapy Social and behavioral science Rapid publication of emerging sequence information.
Source: LetPub
Research area (LetPub): Virology
Main research topics OpenAlex counts of recent articles; shares are approximate
- HIV Research and TreatmentImmunology and Microbiology30.5%
- HIV/AIDS drug development and treatmentMedicine15.6%
- HIV/AIDS Research and InterventionsMedicine13.9%
- Immune Cell Function and InteractionImmunology and Microbiology6.7%
- HIV-related health complications and treatmentsMedicine3.8%
- T-cell and Retrovirus StudiesImmunology and Microbiology3.3%
- Cytomegalovirus and herpesvirus researchMedicine2.9%
- Animal Disease Management and EpidemiologyAgricultural and Biological Sciences2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Virology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Virology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
| Minor | Virology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.03LetPub ·
- CiteScore 2026-06
- 2.9LetPub ·
- SJR 2026-06
- 0.52LetPub ·
- SNIP 2026-06
- 0.52LetPub ·
- h-index
- 87LetPub ·
- h-index
- 128OpenAlex ·
- i10-index
- 4,326OpenAlex ·
- 2-year mean citedness
- 1.35OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 8.98%LetPub ·
Volume
- Articles per year
- 64LetPub ·
Articles by year OpenAlex count · 7,888 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 33 | 3 | 0 |
| 2025 | 67 | 19 | 71 |
| 2024 | 72 | 34 | 162 |
| 2023 | 100 | 38 | 354 |
| 2022 | 97 | 50 | 596 |
| 2021 | 133 | 74 | 1,035 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Mary Ann Liebert Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1987
- ISSN
- 0889-2229
- Electronic ISSN
- 1931-8405
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about AIDS Research and Human Retroviruses
What CAS zone is AIDS Research and Human Retroviruses in?
In the 2025 upgraded edition of the CAS Journal Ranking, AIDS Research and Human Retroviruses is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology / Infectious Diseases / Virology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of AIDS Research and Human Retroviruses?
The latest impact factor listed by LetPub is 1.03; CiteScore 2.9, h-index 128.
How long does peer review take at AIDS Research and Human Retroviruses?
Authors report an average review time of 3–6 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index AIDS Research and Human Retroviruses?
According to LetPub and DOAJ records, AIDS Research and Human Retroviruses is indexed in SCIE and Scopus.
Is AIDS Research and Human Retroviruses open access, and what is the APC?
AIDS Research and Human Retroviruses is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .